Thank you, Mr. Chair. That's very helpful to know.
The one thing I would leave to the business that we have to deal with as a committee is the timing of it. I just think that we should resolve as a committee to make that our first study that we're going to do on our own initiative. I agree that legislation from the House takes priority, so we'll have to deal with that, and Bill S-5, for sure. I think it's at second reading. It hasn't been moved on the order paper yet.
Some of the private members' bills, like the one on drinking water, we have to do by April. The other one, on health research, we have a year, and quite honestly, I don't know how many meetings. That actually duplicates some of the pharmacare study that we had. It does touch on ways to make drugs more affordable, so I personally would not be in favour of devoting very much time to that study. The motion doesn't say how many meetings we have to have. We could have one meeting. We could have a couple of meetings on it. However, I think it's important for this committee to be masters of its own business. What we move as a subject to study should be a reflection of what we think is an important issue, and again, I just can't think of one that's more important than indigenous health.